ATXA Therapeutics
Daniel O'Mahony is a board member at ATXA Therapeutics. Daniel has also served as the Director of Technology Transfer at NUI Galway, where they were responsible for commercialising all IP developed at the university, including licensing, spin-outs and spin-ins.
Daniel O'Mahony has a degree in biochemistry from University College Cork.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
ATXA Therapeutics
ATXA is focusing on late-stage preclinical & clinical development of novel small molecule drugs to treat Pulmonary Arterial Hypertension.